Personnel News
Discover the latest personnel news. Stay informed about executive appointments, leadership changes, and significant personnel movements across various industries. Get updates on the individuals shaping business strategies and operations.
May 27, 2026 at 4:33 PM
ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation
DUBLIN--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation...
May 27, 2026 at 4:30 PM
Six Flags Appoints Ash Walia Chief Financial Officer
CHARLOTTE, N.C.--(BUSINESS WIRE)--Six Flags Appoints Ash Walia Chief Financial Officer...
May 27, 2026 at 4:15 PM
BuzzFeed, Inc. Completes Majority Stake Investment by Byron Allen's Family Office, Positioning Company for Next Era of Growth
NEW YORK--(BUSINESS WIRE)--BuzzFeed, Inc. Completes Majority Stake Investment By Byron Allen's Family Office...
May 27, 2026 at 4:15 PM
Zurn Elkay Water Solutions Announces Executive Promotions
MILWAUKEE--(BUSINESS WIRE)--Zurn Elkay Water Solutions Corporation (NYSE: ZWS) announced today the promotion of Dave Pauli, 44, to the position of Chief Operating Officer (COO), reporting to Todd A. Adams, Chairman and CEO. Pauli will oversee all of the company’s operations, supply chain management and information technology, focusing on operational excellence and executing the company’s strategic plan initiatives. Dan Klun, 51, is being promoted to the role of Chief Financial Officer (CFO), al...
May 27, 2026 at 4:15 PM
Tredegar Announces Director Transitions
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Announces Director Transitions...
May 27, 2026 at 2:41 PM
Alesis LLC Expands to the Pacific Northwest With Dr. Lyly Fisher — First Seattle-Area Provider of Alesis OSA1™
COCOA BEACH, Fla. & SEATTLE--(BUSINESS WIRE)--Alesis LLC, the U.S. distributor of the Alesis OSA1™ medical device, today announced a joint venture partnership with Dr. Lyly Fisher, DDS, Diplomate, ABDSM, ASBA -- a dual board-certified sleep dentist with offices in Seattle and Renton, Washington. Dr. Fisher is the first sleep dentist in the Seattle area to offer Alesis OSA1, a breakthrough non-surgical treatment for patients with obstructive sleep apnea (OSA) who cannot tolerate CPAP therapy. Th...
May 27, 2026 at 2:16 PM
UWP Co-Founder Pens Op/Ed on Changing Industry Dynamics
DENVER--(BUSINESS WIRE)--There can be an illusion of ownership in wealth management aggregator models. Advisors considering a breakaway need to answer these questions....
May 27, 2026 at 1:55 PM
Yieldmo Appoints Anthony Flaccavento as Chief Revenue Officer, Expands Executive Leadership Team
NEW YORK--(BUSINESS WIRE)--Yieldmo, a leading advertising platform improving digital ad experiences through creative tech and AI, today announced the appointment of Anthony Flaccavento as Chief Revenue Officer (CRO). In this role, Flaccavento will oversee all aspects of Yieldmo’s global revenue organization, including sales, account management, supply partnerships, and overall go-to-market execution. Flaccavento joins Yieldmo as the company continues to accelerate growth and expand its offering...
May 27, 2026 at 1:00 PM
LCNB Corp. Strengthens Columbus Banking Presence with Two Additions
LEBANON, Ohio--(BUSINESS WIRE)--LCNB Corp. (Nasdaq: LCNB, the “Company”) today announced that its wholly owned subsidiary, LCNB National Bank (the “Bank”), added two experienced banking professionals to its Columbus team, further strengthening the Bank’s presence and commitment to the region. Jeff Beyke has joined the Bank as a market leader, senior vice president, serving the Columbus market. He will work alongside William (Will) Newell, who recently joined LCNB as branch officer and assistant...
May 27, 2026 at 12:34 PM
PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization Ahead of Potential Launch of BESREMi® in Essential Thrombocythemia
BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical company headquartered in Taiwan, announced that Eric Vogel has joined the company as U.S. Head of Commercialization. A seasoned commercial leader with more than 20 years of experience in oncology and hematology, Vogel will support Samuel Lin, Head of Global Operations, in driving the commercial growth of BESREMi® (ropeginterferon alfa-2b-njft) for approved uses across global markets. Vogel jo...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.